PROS1 and neoplasm: EVs can establish PMNs and support rapid tumor dissemination to transport cargoes such as nucleic acids and proteins, influencing various signaling pathways, suppressing defensive immune reactions, polarizing tumor-promoting phenotypes, expressing the PD-1 checkpoint protein (208), and targeting EVs represents a promising therapeutic strategy (207).